Imágen hair care supports Latinas in Business Awards
TAMPA BAY, Fla. — The Stephan Co., a maker of hair care and skin care products, has announced that its Imágen hair care brand is supporting the Los Angeles Chapter of the National Latina Business Women Association's 11th Annual Latinas in Business Awards.
The awards honor Latinas in the L.A.-area who have excelled in various aspects of the business world. Candidates from across a range of industries are nominated for specific categories by NLBWA-LA members.
Courtesy of the Stephan Company, each of the winners and all 400 attendees at the event will receive Imágen Salon Formula, a new hair care line designed specifically to meet the hair care needs of Latinas.
Currently available at Target, Imágen Salon Formula consists of six, hair care products: shampoo, conditioner, leave-in conditioner, temporary straightener, shine mist and anti-frizz serum.
NABP announces pharmacy domains
MOUNT PROSPECT, Ill. — As the registry operator of the new .pharmacy domain, the National Association of Boards of Pharmacy, under a contract with the Internet Corporation for Assigned Names and Numbers, will soon provide a means for identifying safe online pharmacies and resources.
Under the Association's Registry Agreement, executed with ICANN on June 19, 2014, the new .pharmacy generic top-level Domain will be available only to legitimate online pharmacies and related entities located in the United States or other countries. The Registry Agreement also includes a number of safeguards intended to protect consumers.
NABP plans to launch the .pharmacy gTLD by fall 2014, and is currently operationalizing policies to ensure that only legitimate website operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .pharmacy. These eligibility requirements for the .pharmacy gTLD were developed in partnership with a global coalition of stakeholders and address a shared concern about illegal online drug sellers distributing products.
"Amidst a proliferation of rogue websites selling counterfeit and substandard drug products, the .pharmacy domain will give consumers an easy way to be assured that they are using a safe, legitimate Internet pharmacy," stated NABP president Joseph Adams. "Toward this goal, NABP is very pleased to become an official registry operator under the agreement with ICANN and to be moving forward with steps to launch the new .pharmacy gTLD."
The next step for the .pharmacy gTLD is the registry onboarding process, which includes performance of pre-delegation testing to ensure that NABP and its technical partners have the capacity to operate the new .pharmacy gTLD in a stable and secure manner. Additionally, as the registry operator, NABP will contract with registrars that agree to ensure domain name registrants are in compliance with the established .pharmacy standards.
NABP has been working toward completion of these steps since May 2013 when the .pharmacy proposal passed ICANN's initial evaluation. The Association also has launched an informational website, DotPharmacy.net, which includes program updates and a request-for-information form for entities seeking a .pharmacy gTLD. Application instructions for entities seeking a .pharmacy gTLD will be included on the site to coincide with the launch. In July 2014, NABP will convene a meeting of the .pharmacy gTLD advisory committee to discuss implementation of the program standards and to continue fostering collaborative international partnerships.
NABP continues to monitor websites selling prescription drugs to patients in the US and, as of June 2014, has reviewed over 10,790 Internet drug outlets and found 97% of them to be out of compliance with pharmacy laws and practice standards established in the U.S. to protect the public health. Of the 10,432 websites identified as "Not Recommended," nearly half offer foreign or non-Food and Drug Administration-approved drugs, many of which may be dangerous counterfeits, to unsuspecting U.S. patients. Further, health and regulatory agencies in the U.S. and abroad have reported cases of patients harmed by counterfeit, substandard, and adulterated medications distributed by illegal Internet sellers.
Among the global coalition of stakeholders behind the .pharmacy initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, FDA, Gilead Sciences, International Pharmaceutical Federation, INTERPOL, Janssen Pharmaceuticals, LegitScript, Merck/MSD, National Association of Pharmacy Regulatory Authorities, Pfizer and state boards of pharmacy.
CVS Caremark’s SilverScript inks collaborations with ACOs
WOONSOCKET, R.I. — SilverScript Insurance Co., a CVS Caremark company, has entered into collaborations with seven accountable care organizations across the country.
The collaborations are designed to help improve pharmacy care for Medicare Part D beneficiaries who are served by the participating ACO and also enrolled in a SilverScript Medicare Part D Prescription Drug Plan, the company stated.
The collaborating ACOs include Monarch Healthcare ACO and National ACO in California; American Health Alliance, Orange Accountable Care, Orange Accountable Care of South Florida, and West Florida ACO in Florida; and VirtualCare ACO in New Jersey.
"Our expertise and access to patient prescription data can help these Accountable Care Organizations identify those Medicare Part D patients who could benefit from interventions designed to improve medication adherence, reduce gaps in care and help reduce overall pharmacy spend," stated Troyen A. Brennan, chief medical officer, CVS Caremark. "We believe this partnership can help our ACO partners improve key quality measures for their Medicare patients and improve health outcomes in line with our purpose of helping people on their path to better health."
Through the collaboration, clinicians at the participating ACOs will be able to track prescription activity and usage for the SilverScript beneficiaries they treat, including the use of generic versus brand prescriptions and the identification of any medication adherence issues or gaps in care. Based on this information, they will work to develop and implement appropriate interventions.
As a Medicare Part D PDP sponsor, SilverScript implements a medication therapy management program that includes medication reviews and other adherence and gaps in care programs that enhance the coordination of pharmacy care for beneficiaries. Through these programs, SilverScript beneficiaries are counseled individually about maintenance medications, patient concerns and any potential risks. These programs are designed to identify concerns around adherence to maintenance medications and possible risks, such as drug-to-drug interactions, duplicate therapies or high-risk medications.
These seven Accountable Care Organizations join an existing group of ACOs across the country that SilverScript has been working in collaboration with to improve pharmacy care for the Medicare Part D beneficiaries they serve. These ACOs include PriMed in Connecticut, Franciscan Alliance ACO in Indiana, Jordan Community ACO in Massachusetts, Dartmouth-Hitchcock Health in New Hampshire, and Atlantic ACO in New Jersey.